Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Titel:
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Auteur:
Seddon, Beatrice Strauss, Sandra J Whelan, Jeremy Leahy, Michael Woll, Penella J Cowie, Fiona Rothermundt, Christian Wood, Zoe Benson, Charlotte Ali, Nasim Marples, Maria Veal, Gareth J Jamieson, David Küver, Katja Tirabosco, Roberto Forsyth, Sharon Nash, Stephen Dehbi, Hakim-Moulay Beare, Sandy
Verschenen in:
Lancet oncology
Paginering:
Jaargang 18 (2017) nr. 10 pagina's 1397-1410
Jaar:
2017
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license